Trial intelligence / Profile preview

Lyophilized live attenuated varicella vaccine Phase III trial

CTR20170285Phase 3Completed

Sponsor
Wantai BioPharm
Start
Mar 2018
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of Minhai varicella vaccine in chickenpox, sponsored by Wantai BioPharm. Started Mar 2018; status: completed.

02

Drugs

Minhai varicella vaccine
03

Conditions

chickenpox

Beyond the preview

Go deeper on CTR20170285.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20170285.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call